Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study
Silvia Montoto(Queen Mary University of London), Hervé Tilly(Centre Virchow-Villermé), Corinne Haïoun(Assistance Publique – Hôpitaux de Paris), Nöel Milpied(Hôpital Cardiologique du Haut-Lévêque), Augustin Ferrant(Cliniques Universitaires Saint-Luc), Christophe Fruchart(Centre François Baclesse), Carmen Canals(Hospital de Sant Pau), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), E. Condé(University of Bern), L Fouillard(Unknown), Christian Gisselbrecht(Institut Universitaire de France), T. Andrew Lister(St Bartholomew's Hospital), Anthony H. Goldstone(Royal London Hospital), V. Leblond(Université Sorbonne Nouvelle), S Slavin(N. I. Lobachevsky State University of Nizhny Novgorod), A. Z. S. Rohatiner(Institute of Cancer Research), Norbert Schmitz(University Hospital Münster), G. Taghipour
Cited by 146
Related Papers
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma
|The Journal of Experimental Medicine|2003|1.1k